PMID- 35370956 OWN - NLM STAT- MEDLINE DCOM- 20220405 LR - 20220519 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 13 DP - 2022 TI - A MEN1 Patient Presenting With Multiple Parathyroid Adenomas and Transient Hypercortisolism: A Case Report and Literature Review. PG - 802453 LID - 10.3389/fendo.2022.802453 [doi] LID - 802453 AB - BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is a hereditary endocrine syndrome caused by mutations in MEN1 tumor suppressor gene. CASE PRESENTATION: A 53-year-old Chinese female was admitted to Division of Endocrinology, Tongji Hospital, for hypercalcemic crisis. Increased level of parathyroid hormone (PTH) was confirmed by laboratory tests, and imaging examination showed multiple parathyroid adenomas. Based on gene analysis, the patient was diagnosed as MEN1 associated hyperparathyroidism (HPT) by gene analysis with c.1378C>T (p.Arg460Ter) mutation in MEN1 gene. Her condition was complicated by transient hypercortisolism, mammary mass and uterine leiomyoma. After subtotal parathyroidectomy, PTH and serum calcium levels returned to normal. CONCLUSION: HPT with multiple parathyroid adenomas is an indication of MEN1 gene mutation. Serum cortisol and its circadian rhythm can be abnormal in the presence of hypercalcemia and high PTH. These parameters can return to normal after parathyroidectomy. CI - Copyright (c) 2022 Chen, Xu, Yue, Yu and Shao. FAU - Chen, Fuqiong AU - Chen F AD - Division of Endocrinology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, China. AD - Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, China. FAU - Xu, Qinqin AU - Xu Q AD - Division of Endocrinology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, China. AD - Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, China. FAU - Yue, Wenzhu AU - Yue W AD - Division of Endocrinology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, China. AD - Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, China. FAU - Yu, Xuefeng AU - Yu X AD - Division of Endocrinology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, China. AD - Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, China. FAU - Shao, Shiying AU - Shao S AD - Division of Endocrinology, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, China. AD - Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, China. LA - eng PT - Case Reports PT - Review DEP - 20220308 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 SB - IM MH - *Cushing Syndrome/etiology/genetics MH - Female MH - Humans MH - *Hypercalcemia/complications MH - *Hyperparathyroidism MH - Middle Aged MH - *Multiple Endocrine Neoplasia Type 1/complications/diagnosis/genetics MH - *Parathyroid Neoplasms/complications/genetics/surgery PMC - PMC8965320 OTO - NOTNLM OT - hypercalcemia OT - hypercortisolism OT - hyperparathyroidism OT - multiple endocrine neoplasia type 1 OT - parathyroid adenomas COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/04/05 06:00 MHDA- 2022/04/06 06:00 PMCR- 2022/01/01 CRDT- 2022/04/04 05:28 PHST- 2021/11/16 00:00 [received] PHST- 2022/01/21 00:00 [accepted] PHST- 2022/04/04 05:28 [entrez] PHST- 2022/04/05 06:00 [pubmed] PHST- 2022/04/06 06:00 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2022.802453 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2022 Mar 8;13:802453. doi: 10.3389/fendo.2022.802453. eCollection 2022.